"It is integrated into everything that we do," says Merck's chief information and digital officer Dave Williams.

Zacks Research lowered their Q3 2024 earnings estimates for Merck & Co., Inc. in a report issued on Monday, October 21st.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

Merck (MRK) reachead $106.64 at the closing of the latest trading day, reflecting a +0.28% change compared to its last close.

The Industry is on the brink of a substantial surge, with the market size expected to reach USD 100 Million in 2023 and ...

Report on how AI is driving market transformation - The Oncology Market in India  size is estimated to grow by USD 1.49 ...

Chicago, IL – October 22, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...

Empowering young women with the confidence to excel in their education is key to inspiring the next generation' ...

Researchers reported that an interim analysis showed DFS favored pembrolizumab (hazard ratio, 0.31), with median DFS not reached in either group.

Jefferies analyst Akash Tewari has assigned their bullish stance on ARVN stock, giving a Buy rating yesterday. Akash Tewari’s rating is ...

Rheumatic heart disease is a serious complication resulting from rheumatic fever, which primarily affects children and young ...

© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.